ReviewNaunyn-Schmiedeberg's archives of pharmacology2025
Marine life as a source of anti-prostate cancer agents: an updated overview (2003-2023).
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Marine-Derived Steroids for Cancer Treatment: Search for Potential Selective Glucocorticoid Receptor Agonists/Modulators (SEGRAMs).Marine drugs · 2025Review
- Cynthichlorine Extracted from AscidianMarine drugs · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Cancer is the deadliest threat that human beings are currently facing. Prostate cancer is the second largest cancer in males all over the world. During the last decade, scientists made breakthroughs in combatting this deadliest threat through naturally identified drugs. As in the majority of the cases, the natural products have been reported as non-toxic to the healthy cells of the body; therefore, scientists are taking special interest in identifying those and making tiresome efforts to isolate compounds from the naturally occurring living resources. Marine natural products are given a special preference over other natural products because of their diverse atmospheric and structural variations as well as signaling pathways for carcinogenesis. This study covers the anti-prostate cancer agents extracted from marine organisms including algae, fungi, bacteria, sponges, soft-bodied corals, fish, and other miscellaneous organisms. These natural products belong to different classes such as terpenes, terpenoids, carotenoids, alkaloids, polyketides, peptides, lactones, quinones, polysaccharides, and steroids. These compounds act against prostate cancer cells via in vitro and in vivo pathways, show special affinity towards the targeted area, and are specific because they bind to specific signaling paths. This review article covers data published from 2003 to 2023, which consists of anti-prostate cancer agents from marine sources.
Indexed as
Identifiers
39976719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.